JavaScript Required

Jumpseat Aerospace News requires JavaScript to function. Please enable JavaScript in your browser settings to continue.

FAA Drops EpiPen Mandate in New Emergency Kit Rule

August 7, 2026

2 min read

Key Takeaways

FAA proposes eliminating standardized emergency kit lists.
Airlines will choose contents to treat nine major medical emergencies.
EpiPens not required, despite campaigner pressure.
Opioid reversal medications will be mandatory.

Silver membership required Upgrade to Silver to access Key Takeaways.

Upgrade

Strategic Implications

This change may indicate a shift towards more flexible and modern medical practices in aviation, which could benefit airlines by allowing them to adapt to new medical advancements. The decision not to mandate EpiPens suggests the FAA may prioritize cost savings and flexibility over specific medical equipment requirements, which could have implications for passenger safety and airline liability.

Silver membership required Upgrade to Silver to access Strategic Implications.

Upgrade

What Happened

Regulatory Change Gives Airlines Flexibility Over Medical Supplies

The Federal Aviation Administration (FAA) is planning to eliminate standardized lists for emergency medical kits on US airlines, giving carriers flexibility to choose contents that can treat nine major life-threatening conditions. The proposed rulemaking, which stems from the FAA Reauthorization Act of 2024, would require airlines to stock opioid reversal medications but does not mandate EpiPens for treating allergic reactions. The change aims to promote modern medical practices and reduce costs for airlines. This development was reported by an unknown source.

Source | Originally Published: August 4, 2026

Companies Mentioned